Aging and insulin sensitivity: role of blood pressure and sympathetic nervous system activity. 1993

M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
Department of Internal Medicine, University of Michigan, Ann Arbor.

BACKGROUND The purpose of this study was to determine whether age is a predictor of sensitivity to the peripheral effects of insulin on carbohydrate metabolism independent of the potential influences of the level of sympathetic nervous system (SNS) activity and blood pressure (BP). METHODS In 60 human subjects (age range 19-78 years), insulin sensitivity, SI, was determined from glucose and insulin levels obtained during an intravenous glucose tolerance test, and plasma norepinephrine (NE) levels were measured to estimate SNS activity. RESULTS There were age-associated increases in plasma NE level (r = .585; p < .001) and mean arterial BP (r = .516; p < .001), and an age-associated decline in SI (r = -.352; p = .04). However, in stepwise multiple regression analysis, body mass index (BMI) and mean arterial BP were the only independent predictors of SI, accounting for 43% of the variance in SI; age, plasma NE level, plasma epinephrine level, and fasting plasma glucose did not enter the model. Although these results suggest an age-associated decline in insulin sensitivity, this decline appears to be associated with BMI and mean arterial BP rather than aging per se. In addition, the age-associated increase in SNS activity was not found to be an independent predictor of insulin sensitivity. CONCLUSIONS This study demonstrates that in addition to BMI, blood pressure should be considered as another confounding factor in studies of insulin sensitivity in human aging.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
March 1996, Journal of hypertension,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
January 1993, Japanese circulation journal,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
January 2001, Clinical and experimental hypertension (New York, N.Y. : 1993),
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
September 2011, American journal of hypertension,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
February 2002, American journal of hypertension,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
May 1991, Annals of epidemiology,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
July 1999, Hypertension (Dallas, Tex. : 1979),
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
June 1982, The Journal of clinical endocrinology and metabolism,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
January 1979, Nephron,
M A Supiano, and R V Hogikyan, and L A Morrow, and F J Ortiz-Alonso, and W H Herman, and A T Galecki, and J B Halter
January 2004, Blood pressure,
Copied contents to your clipboard!